EGFR overexpression has been reported in up to 90% of human head and neck squamous cell carcinomas (HNSCC) and also in feline oral squamous cell carcinoma (OSCC), making it an interesting therapeutic target in both species 39-41. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.